354 related articles for article (PubMed ID: 28601421)
61. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
[TBL] [Abstract][Full Text] [Related]
62. Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option.
Dorji K; Phuntsho S; Pempa ; Kumluang S; Khuntha S; Kulpeng W; Rajbhandari S; Teerawattananon Y
Vaccine; 2018 Mar; 36(13):1757-1765. PubMed ID: 29478752
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned.
La Vincente SF; von Mollendorf C; Ulziibayar M; Satzke C; Dashtseren L; Fox KK; Dunne EM; Nguyen CD; de Campo J; de Campo M; Thomson H; Surenkhand G; Demberelsuren S; Bujinlkham S; Do LAH; Narangerel D; Cherian T; Mungun T; Mulholland EK
BMC Public Health; 2019 Mar; 19(1):333. PubMed ID: 30898094
[TBL] [Abstract][Full Text] [Related]
64. Pneumococcal serotype evolution in Western Europe.
Tin Tin Htar M; Christopoulou D; Schmitt HJ
BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
[TBL] [Abstract][Full Text] [Related]
65. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.
Vila-Corcoles A; Ochoa-Gondar O; de Diego C; Satue E; Aragón M; Vila-Rovira A; Gomez-Bertomeu F; Magarolas R; Figuerola-Massana E; Raga X; Perez MO; Ballester F
BMC Infect Dis; 2018 Apr; 18(1):196. PubMed ID: 29699550
[TBL] [Abstract][Full Text] [Related]
66. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
67. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness.
Ochoa-Gondar O; Figuerola-Massana E; Vila-Corcoles A; Aguirre CA; de Diego C; Satue E; Gomez F; Raga X;
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2104-8. PubMed ID: 26453272
[TBL] [Abstract][Full Text] [Related]
68. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
[TBL] [Abstract][Full Text] [Related]
69. Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children.
Lewnard JA; Givon-Lavi N; Dagan R
Clin Infect Dis; 2021 Oct; 73(7):e1423-e1433. PubMed ID: 33346348
[TBL] [Abstract][Full Text] [Related]
70. [Pneumococcal vaccination for children and adults].
Albrich W
Ther Umsch; 2016; 73(5):235-40. PubMed ID: 27268445
[TBL] [Abstract][Full Text] [Related]
71. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.
Ladhani SN; Collins S; Djennad A; Sheppard CL; Borrow R; Fry NK; Andrews NJ; Miller E; Ramsay ME
Lancet Infect Dis; 2018 Apr; 18(4):441-451. PubMed ID: 29395999
[TBL] [Abstract][Full Text] [Related]
72. Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England.
Saxena S; Atchison C; Cecil E; Sharland M; Koshy E; Bottle A
J Infect; 2015 Oct; 71(4):428-36. PubMed ID: 26159503
[TBL] [Abstract][Full Text] [Related]
73. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.
Alicino C; Paganino C; Orsi A; Astengo M; Trucchi C; Icardi G; Ansaldi F
Vaccine; 2017 Oct; 35(43):5776-5785. PubMed ID: 28911902
[TBL] [Abstract][Full Text] [Related]
74. The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015.
Akata K; Chang B; Yatera K; Kawanami T; Naito K; Noguchi S; Kido T; Mukae H
J Infect Chemother; 2017 May; 23(5):301-306. PubMed ID: 28262532
[TBL] [Abstract][Full Text] [Related]
75. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
Vaccine; 2019 May; 37(20):2687-2693. PubMed ID: 30975569
[TBL] [Abstract][Full Text] [Related]
76. Pneumococcal Vaccination and Pneumonia Associated With Pleural Effusion in a Pediatric Population.
Bernaola E; Gil F; Herranz M; Gil-Setas A; Guevara M; Castilla J
Pediatr Infect Dis J; 2018 Apr; 37(4):e87-e92. PubMed ID: 28938258
[TBL] [Abstract][Full Text] [Related]
77. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
[TBL] [Abstract][Full Text] [Related]
78. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
Baxter R; Aukes L; Pelton SI; Yee A; Klein NP; Gruber WC; Scott DA; Center KJ
J Pediatric Infect Dis Soc; 2021 Mar; 10(2):141-150. PubMed ID: 32415771
[TBL] [Abstract][Full Text] [Related]
79. Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization.
Madhi SA; Nzenze SA; Nunes MC; Chinyanganya L; Van Niekerk N; Kahn K; Twine R; De Gouveia L; Von Gottberg A; Shiri T
Expert Rev Vaccines; 2020 Apr; 19(4):383-393. PubMed ID: 32237932
[TBL] [Abstract][Full Text] [Related]
80. Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
Dondo V; Mujuru H; Nathoo K; Jacha V; Tapfumanei O; Chirisa P; Manangazira P; Macharaga J; de Gouveia L; Mwenda JM; Katsande R; Weldegebriel G; Pondo T; Matanock A; Lessa FC
Clin Infect Dis; 2019 Sep; 69(Suppl 2):S72-S80. PubMed ID: 31505631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
